Mark Wilterding | Vice President, Investor Relations & Treasurer |
Mike Mussallem | Chairman & Chief Executive Officer |
Scott Ullem | Chief Financial Officer |
Larry Biegelsen | Wells Fargo |
Robbie Marcus | JPMorgan |
Matt Miksic | Credit Suisse |
William Plovanic | Canaccord Genuity |
Shagun Singh | RBC Capital Markets |
Cecilia Furlong | Morgan Stanley |
Josh Jennings | Cowen |
Rick Wise | Stifel Nicolaus |
Greetings, and welcome to the Edwards Lifesciences First Quarter 2022 Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note that this conference is being recorded. I will now turn the conference over to our host, Mark Wilterding, Vice President of Investor Relations and Treasurer.